Federal award
NEUREN PHARMACEUTICALS, INC.
W81XWH0910496
Assistance
Obligated and Ceiling
- Obligated (net)
- $27,492,373.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $27,518,373.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- NEUREN PHARMACEUTICALS, INC. · HMVBDJ9HCXU4
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 9700
- Funding agency
- —
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH0910496
- Award type code
- 04
- Actions
- 12 · Jun 26, 2009 to Jul 25, 2014
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jul 25, 2014 | FY2014 | 0013 | B1 | $1,487,951.00 | — |
| Jul 8, 2014 | FY2014 | 0012 | B1 | $1,482,870.00 | — |
| Apr 24, 2013 | FY2013 | 0011 | B1 | $2,773,081.00 | — |
| Sep 27, 2012 | FY2012 | 0010 | FX | −$26,000.00 | — |
| Apr 20, 2012 | FY2012 | 0009 | B1 | $1,661,000.00 | — |
| Dec 27, 2011 | FY2012 | 0008 | B1 | $527,301.00 | — |
| Mar 24, 2011 | FY2011 | 0007 | B1 | $3,765,000.00 | — |
| Jan 14, 2011 | FY2011 | 0006 | B1 | $803,872.00 | — |
| Nov 1, 2010 | FY2011 | 0005 | B1 | $435,298.00 | — |
| Aug 17, 2010 | FY2010 | 0004 | B1 | $757,000.00 | — |
| Apr 15, 2010 | FY2010 | 0002 | B1 | $2,295,000.00 | — |
| Jun 26, 2009 | FY2009 | — | A1 | $11,530,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.